The disorders of hemostasis and their prevention with low-molecular heparins in oncological patients

• Published in: Klinicheskaia laboratornaia diagnostika Vol. 59; no. 7; p. 21
• Main Authors: Somonova, O V, Kushlinskiĭ, N E
• Format: Journal Article
• Language: Russian
• Published: Russia (Federation) 01.07.2014
• Subjects: Anticoagulants - administration & dosage; Biomarkers - blood; Disseminated Intravascular Coagulation - blood; Disseminated Intravascular Coagulation - drug therapy; Disseminated Intravascular Coagulation - etiology; Female; Hemostasis; Heparin, Low-Molecular-Weight - administration & dosage; Humans; Male; Neoplasms - blood; Neoplasms - drug therapy; Thrombosis - blood; Thrombosis - drug therapy; Thrombosis - etiology

The patients with malignant neoplasms are subjected to high risk of development of venous and arterial thromboembolic disease. The development of thrombosis complicates treatment and deteriorates indicators of survival. The alterations in the system of hemostasis brought on by both tumor and methods...